MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Phase 2
Conditions
Urothelial Carcinoma
Interventions
First Posted Date
2015-08-28
Last Posted Date
2022-03-08
Lead Sponsor
Samsung Medical Center
Target Recruit Count
19
Registration Number
NCT02535650
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

Phase 3
Conditions
Laryngopharyngeal Reflux Disease
Interventions
First Posted Date
2015-08-26
Last Posted Date
2016-06-01
Lead Sponsor
Samsung Medical Center
Target Recruit Count
200
Registration Number
NCT02533349
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

A New Track Ablation Device for Liver Biopsy: A Feasibility Study

Phase 1
Conditions
Liver Neoplasms
Interventions
Device: Biopsy Track Ablator (STARmed, Goyang, Korea)
First Posted Date
2015-08-13
Last Posted Date
2015-08-13
Lead Sponsor
Samsung Medical Center
Target Recruit Count
20
Registration Number
NCT02521129

Adjuvant Durvalumab for Esophageal Cancer

Phase 2
Conditions
Esophageal Cancer
Interventions
Drug: Placebo
First Posted Date
2015-08-11
Last Posted Date
2019-12-09
Lead Sponsor
Samsung Medical Center
Target Recruit Count
86
Registration Number
NCT02520453
Locations
🇰🇷

Samsung Medical Center, Seoul, MA, Korea, Republic of

The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease

Phase 2
Conditions
Coronary Syndrome
Interventions
Drug: Combination
Drug: Placebo of Rosuvastatin/Olmesartan(Combination)
First Posted Date
2015-08-06
Last Posted Date
2015-08-06
Lead Sponsor
Samsung Medical Center
Target Recruit Count
504
Registration Number
NCT02516826
Locations
🇰🇷

Cardiac and Vascular Center; Samsung Medical Center, Seoul, Korea, Republic of

Thoracic Epidural for Postoperative Ileus

Not Applicable
Completed
Conditions
Ileus
Interventions
Drug: iv-PCA
Procedure: thoracic epidural analgesia
First Posted Date
2015-07-08
Last Posted Date
2015-07-08
Lead Sponsor
Samsung Medical Center
Target Recruit Count
28
Registration Number
NCT02491385
Locations
🇰🇷

Samsung medical center, Seoul, Korea, Republic of

EAA/Therapy for Treating Children With ADHD

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
First Posted Date
2015-06-26
Last Posted Date
2015-06-26
Lead Sponsor
Samsung Medical Center
Target Recruit Count
46
Registration Number
NCT02482649
Locations
🇰🇷

Yoo-Sook Joung, Seoul, Korea, Republic of

Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

Phase 4
Completed
Conditions
Overactive Bladder
Interventions
First Posted Date
2015-06-10
Last Posted Date
2018-02-28
Lead Sponsor
Samsung Medical Center
Target Recruit Count
434
Registration Number
NCT02468375
Locations
🇰🇷

Samsung Medical Center, Seoul,, Korea, Republic of

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2015-06-03
Last Posted Date
2015-06-03
Lead Sponsor
Samsung Medical Center
Target Recruit Count
90
Registration Number
NCT02461056
Locations
🇰🇷

Samsung medical center, Seoul, Korea, Republic of

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

Phase 2
Conditions
Advanced, Refractory Cancer
Interventions
First Posted Date
2015-06-03
Last Posted Date
2022-06-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
14
Registration Number
NCT02461849
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath